Cognitive performance, neuroplasticity, dementia prevention, and brain aging research
493 articles
New review reveals how engineered peptides could revolutionize Alzheimer's therapy by targeting multiple disease pathways simultaneously.
New research reveals how GFAP protein actively shapes brain aging and could enable early detection of neurodegenerative diseases.
New research reveals combined treatments targeting multiple brain pathways outperform traditional single-drug strategies for Alzheimer's disease.
New research reveals how targeting brain inflammation could unlock novel therapeutic approaches for Alzheimer's disease.
New study combines smartphone sensors, brain scans, and daily check-ins to predict suicide risk in vulnerable patients.
Brain-derived pTau217 blood test shows superior accuracy for detecting Alzheimer's pathology compared to existing tests.
New brain organoid study shows autophagy-boosting compounds can clear harmful tau proteins and rescue synapses in Alzheimer's disease models.
Antibody therapies show promise for preventing Alzheimer's in cognitively healthy people with disease biomarkers.
Recent breakthrough drugs targeting amyloid plaques slow cognitive decline, but combination therapies may unlock better outcomes.
New research reveals that inconsistent sleep timing and quality drive faster accumulation of toxic brain proteins linked to Alzheimer's disease.
Researchers modified astrocytes with chimeric antigen receptors to target amyloid plaques, showing promise for Alzheimer's treatment.
Higher cognitive reserve helps maintain mental sharpness despite age-related brain lesions that disrupt neural connections.
